Virtual Financial Statement As at 31 May 2017 Unit : Baht 2017 2016 Total assets 372,529,473.72 355,559,825.62 Intangible assets - - Total liabilities 345,800.00 817,800.00 Non-Controlling Interests - - Net
total amount value not exceeding 300,000,000 Baht, with 5% interest rate and 1 year tenor, to support business expansion and working capital. The transaction is classified as a receipt of the financial
using the equity method and presented in the Financial Statement as of June 30, 2019, amounted of THB 308,000,000. The value of the investment has been discounted for impairment. Therefore, the disposal
Disposition of Assets’ requirement by using the highest value from the base of net operating profit, the transaction size equals to 165.57% computed from the latest financial statement ended September 30, 2017
Limited for the three months period ended March 31, 2019. And The Audited financial statement of BS Myco Biotech Company Limited for year ended December 31,2018. The calculation of transaction size (1) Book
highest value from the base of net operating profit, the transaction size equals to 165.70% computed from the latest financial statement ended September 30, 2017 (No other acquisition transaction per
past 6 months, is equivalent to 16.88 percent, which is based on the value of total assets in the consolidated financial statement ended March 31, 2019. This 16.88 percent transaction size falls in
following requirements; (1) initially acquires units of a trust not less than ten million baht; or (2) such person in (1) who acquires additional units, which results in the total value of not less than ten